1800-272-662
Shopping Cart 0
countryflagAU
Login

Medical Developments International Ltd

Healthcare AU MVP

0.41AUD
0.005(1.23%)

Last update at 2026-03-13T05:10:00Z

Day Range

0.410.41
LowHigh

52 Week Range

0.390.77
LowHigh

Fundamentals

  • Previous Close 0.41
  • Market Cap46.19M
  • Volume13111
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA1.79M
  • Revenue TTM40.64M
  • Revenue Per Share TTM0.36
  • Gross Profit TTM 30.56M
  • Diluted EPS TTM-

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax 0.17M -32.92600M -7.49200M -15.90800M -14.97800M
Minority interest - - - - -
Net income 0.09M -40.99200M -5.60900M -12.40700M -12.56500M
Selling general administrative 22.14M 32.55M 32.58M 22.21M 15.23M
Selling and marketing expenses 3.94M 2.82M 3.83M 2.60M 4.75M
Gross profit 29.43M 24.37M 22.04M 15.63M 19.10M
Reconciled depreciation 3.20M 3.39M 3.11M 2.94M 3.75M
Ebit 0.14M -32.84000M -0.68800M -15.22400M -6.01300M
Ebitda 1.67M -29.44600M 2.42M -10.68500M -2.26400M
Depreciation and amortization 1.53M 3.39M 3.11M 4.54M 3.75M
Non operating income net other - - - - -
Operating income 3.07M -16.86700M -17.30400M -12.54500M -3.47400M
Other operating expenses 35.98M 50.02M -20.14100M -24.74900M -30.66800M
Interest expense 0.07M 0.09M 0.10M 0.10M 0.00900M
Tax provision 0.07M 8.07M -1.88300M -3.50100M -2.41300M
Interest income 0.38M 0.40M 0.66M 0.04M 0.07M
Net interest income 0.30M 0.32M 0.56M -0.05800M -0.05000M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.07M 8.07M -1.88300M -3.50100M -2.41300M
Total revenue 39.06M 33.15M 32.17M 22.37M 25.27M
Total operating expenses 26.35M 35.41M 42.48M 32.50M 28.82M
Cost of revenue 9.63M 8.78M 10.12M 6.74M 6.17M
Total other income expense net -2.90500M -16.05900M 12.39M -0.58100M -8.95600M
Discontinued operations - - - - -
Net income from continuing ops 0.09M -40.99200M -5.60900M -12.40700M -12.56500M
Net income applicable to common shares 0.09M -40.99200M -5.60900M -12.40700M -12.56500M
Preferred stock and other adjustments - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 66.40M 63.77M 101.31M 92.22M 100.17M
Intangible assets 18.11M - 34.51M 36.88M 34.46M
Earning assets - - - - -
Other current assets - 0.56M 0.79M 0.78M 2.73M
Total liab 11.29M 18.04M 20.00M 34.92M 31.87M
Total stockholder equity 55.10M 45.73M 81.31M 57.30M 68.30M
Deferred long term liab - - 32.70M 35.12M 32.81M
Other current liab - 0.64M 1.59M 4.88M 3.25M
Common stock - 105.73M 105.73M 76.99M 76.89M
Capital stock 115.01M - 105.73M 76.99M 76.89M
Retained earnings -62.76500M -62.85900M -30.15400M -24.54500M -12.13800M
Other liab - - 2.24M 21.98M 22.20M
Good will 3.81M 3.81M 3.81M 3.81M 4.39M
Other assets - 0.00000M 8.11M 40.74M 35.05M
Cash 17.84M 9.73M 24.66M 20.40M 36.28M
Cash and equivalents - - 24.66M 20.40M 36.28M
Total current liabilities 7.82M 9.55M 15.55M 10.48M 6.96M
Current deferred revenue - 0.28M 0.28M 0.08M 0.07M
Net debt - -7.44900M -22.10100M -17.58500M -33.22800M
Short term debt - 0.37M 0.35M 0.35M 0.34M
Short long term debt - - - - -
Short long term debt total - 2.29M 2.56M 2.81M 3.05M
Other stockholder equity - - -75.57500M -52.44700M -64.75700M
Property plant equipment - - 12.12M 11.55M 11.70M
Total current assets 35.54M 26.14M 42.76M 34.37M 47.39M
Long term investments - - - - -
Net tangible assets - - 75.70M 51.74M 62.27M
Short term investments - - - - -
Net receivables 7.53M 7.07M 8.93M 6.08M 2.65M
Long term debt - - - - 0.00000M
Inventory 9.45M 8.77M 8.38M 7.11M 5.73M
Accounts payable 6.49M 8.25M 13.32M 5.17M 3.30M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - 2.86M 5.74M 4.85M 3.54M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - 16.04M -17.73800M -17.11400M 0.00100M
Deferred long term asset charges - - - - -
Non current assets total 30.86M 37.63M 58.55M 57.85M 52.79M
Capital lease obligations 1.99M - 2.56M 2.81M 3.05M
Long term debt total - - 2.21M 2.46M 2.71M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments -1.04000M -3.16900M -7.09900M -5.15900M -6.47800M
Change to liabilities - - 2.36M 0.90M 1.02M
Total cashflows from investing activities -1.04000M -3.16900M -7.66500M -5.21400M -6.56000M
Net borrowings - - -0.25300M -0.21500M -0.23200M
Total cash from financing activities 8.68M -0.80700M 28.06M 0.14M 36.12M
Change to operating activities - - -0.15400M -0.01900M -10.22300M
Net income 0.09M -40.99200M -5.60900M -12.40700M -12.56500M
Change in cash 8.10M -14.92600M 4.26M -15.87900M 20.73M
Begin period cash flow 9.73M 24.66M 20.40M 36.28M 15.54M
End period cash flow 17.84M 9.73M 24.66M 20.40M 36.28M
Total cash from operating activities -0.04300M -10.78000M -16.49500M -10.72200M -8.80800M
Issuance of capital stock 10.01M - 30.00M 0.36M 37.07M
Depreciation 3.20M 3.39M 3.11M 2.94M 3.75M
Other cashflows from investing activities -0.59700M -2.37600M -5.31500M -3.96000M -5.23100M
Dividends paid - - 26.38M 0.14M 35.53M
Change to inventory -0.67900M -0.39300M -1.84200M -1.37400M 0.15M
Change to account receivables -0.58100M 1.86M -2.87000M -2.50000M 1.43M
Sale purchase of stock -0.30400M -0.53300M -1.68400M -0.00300M -0.72700M
Other cashflows from financing activities -1.04000M -0.27400M -0.25300M -0.21500M -0.14100M
Change to netincome - - -12.06100M 1.68M 7.54M
Capital expenditures 0.44M 3.17M 7.67M 5.21M 6.56M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -1.14100M 4.18M -2.50400M -3.59000M -9.92000M
Stock based compensation 1.03M - 1.26M 1.03M 1.17M
Other non cash items -3.23100M 22.64M -5.38100M 9.75M 8.89M
Free cash flow -0.48600M -13.94900M -24.16000M -15.93600M -15.36800M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
MVP
Medical Developments International Ltd		 0.005 1.23% 0.41 - 166.67 1.14 0.83 0.75 11.48
AFP
Aft Pharmaceuticals Ltd		 - -% 3.00 23.08 19.88 1.35 3.81 1.72 13.67
VLS
Vita Life Sciences Ltd		 -0.02 0.80% 2.48 13.89 42.73 1.46 2.42 1.24 6.53
SNT
Syntara Ltd		 -0.001 3.33% 0.03 - 20.45 6.32 4.62 6.32 -2.1607
LGP
Little Green Pharma Ltd		 -0.01 8.70% 0.10 5.25 43.29 0.83 0.41 0.98 19.49

Reports Covered

Stock Research & News

View All

Profile

Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers Penthrox, a trauma and emergency pain relief product for use in hospitals, emergency departments, ambulance services, sport medicines, and for analgesia during short procedures. The company also distributes asthma and chronic obstructive pulmonary disease products, such space chambers, peak flow meters, portable nebulisers, and silicon face mask. Medical Developments International Limited was founded in 1972 and is headquartered in Scoresby, Australia.

Medical Developments International Ltd

4 Caribbean Drive, Scoresby, VIC, Australia, 3179

Key Executives

Name Title Year Born
Mr. Brent MacGregor Chief Exec. Officer 1964
Ms. Anita James Chief Financial Officer NA
Matthew Cramer Chief of Operations & Supply Chain NA
Ms. Tara Eaton Gen. Counsel & Company Sec. NA
Ms. Greer Lucas Head of People & Culture NA
Dr. Scott Courtney Chief Scientific Officer NA
Wai Ng Chi Head of Regulatory Affairs NA
Wayne Pearce Head of Production NA
Mr. Stefaan Schatteman Head of Europe NA
Mr. Brent MacGregor Chief Executive Officer 1964

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.